BMNR (BMNR) Form 144 details planned sale of 152,044 common shares

Rhea-AI Filing Summary

A stockholder of BMNR has filed a notice of proposed sale of 152,044 shares of common stock through UBS Securities LLC on the NYSE, with an approximate sale date of 12/12/2025. The aggregate market value of these planned sales is listed as $5,429,000, compared with 384,067,823 shares of common stock outstanding.

The securities to be sold were acquired on 08/31/2022 from the issuer as GP compensation, with 250,044 shares acquired on that date. Over the past three months, related sales disclosed include 50,000 common shares by Jonathan Bates for gross proceeds of $2,389,663 and 100,000 common shares by Progression Asset Management for gross proceeds of $4,779,326.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS SECURITIES LLC 11 Madison Avenue New York NY 10010	152044	5429000.00	384067823	12/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/31/2022	GP COMPENSATION	ISSUER			250044	08/31/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jonathan BATES 10845 Griffith Peak Drive Las Vegas NV 89135	COMMON	09/22/2025	50000	2389663.00
Progression Asset Management 2018 Vine Street Los Angeles CA 90068	Common	09/22/2025	100000	4779326.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for BMNR disclose?

The Form 144 discloses an intention to sell 152,044 shares of BMNR common stock through UBS Securities LLC on the NYSE, with an aggregate market value of $5,429,000.

How many BMNR shares are proposed to be sold and on which exchange?

The notice covers a proposed sale of 152,044 common shares of BMNR, to be sold on the NYSE.

Which broker is handling the proposed BMNR share sale?

The proposed sale of BMNR common stock is to be executed through UBS Securities LLC, located at 11 Madison Avenue, New York, NY 10010.

When were the BMNR shares to be sold originally acquired and how?

The BMNR common shares to be sold were acquired on 08/31/2022 from the issuer as GP compensation, in an amount of 250,044 shares.

How many BMNR shares are outstanding according to this notice?

The notice states that there are 384,067,823 shares of BMNR common stock outstanding.

What BMNR share sales occurred in the past three months for this account?

Disclosed sales in the past three months include 50,000 common shares by Jonathan Bates for $2,389,663 and 100,000 common shares by Progression Asset Management for $4,779,326.